New strategies for the early detection of pancreatic cancer

Research output: Contribution to journalArticlepeer-review


Pancreatic cancer (PC) remains a deadly disease and early detection through screening is likely to be our best hope to improve survival. Considering the low incidence of PC, population-based screening is not feasible, but is advisable for high-risk patients. Screening individuals at high risk for developing PC leads to the detection of premalignant lesions. High-grade pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm are the targets for early detection of PC. Endoscopic ultrasound (EUS) and magnetic resonance imaging are considered the most accurate techniques for pancreatic imaging; in particular EUS has emerged as a promising imaging test given its potential for tissue sampling to obtain diagnosis and to provide material for molecular profiling of PC. At the moment, screening should be performed within research protocols at experienced centers with a specific clinical and research interest, where a multidisciplinary team of specialists is available.

Original languageEnglish
Pages (from-to)157-159
Number of pages3
JournalExpert Review of Gastroenterology and Hepatology
Issue number2
Publication statusPublished - Feb 1 2016


  • high-risk individuals
  • intraductal papillary mucinous neoplasm
  • Pancreatic cancer
  • pancreatic intraepithelial neoplasia
  • screening

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'New strategies for the early detection of pancreatic cancer'. Together they form a unique fingerprint.

Cite this